Merck KGaA News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia May 25, 2012 -- May 25, 2012, Billerica, MA--EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announced today that John Sweeney, Head of the Life ... (more)

Merck KGaA said it is acquiring an interest in Israeli start-up company QLight Nanotech.

Merck KGaA fell to the lowest price in two months after the German maker of the Erbitux cancer drug reported first-quarter profit that missed analysts' estimates as consumer health and chemicals sales declined.

German drugmaker Merck KGaA said its underlying core profit would rise to 2.8-2.9 billion euro this year, up from 2.73 billion in 2011.

May 14, 2012, Billerica, MA - EMD Millipore, the Life Science division of Merck KGaA of Darmstadt.

Other equities research analysts have also recently issued reports about the stock.

Basel , Mannheim , May 03, 2012 - VAXIMM AG, a Swiss-German biotech spin-off from Merck KGaA focusing on cancer vaccines, announced today the appointment of Jean- Paul Prieels as a new member of its Board of Directors.